Login / Signup

IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments.

Jürgen Wienands
Published in: Therapeutic advances in neurological disorders (2021)
Keyphrases
  • sars cov
  • multiple sclerosis
  • respiratory syndrome coronavirus
  • genome wide
  • peripheral blood
  • white matter
  • gene expression
  • coronavirus disease
  • dna methylation